U.S.
Genmab Up 28%, Axogen Up 31% on Oct 28, 2026: Which Rally Has a Filing Behind It
On Oct 28, 2026, Axogen rose 31.5%, Genmab 28.3% and ICON 17.0%; only Axogen's rise is confirmed by an 8-K.
Phase 3 trial stocks in Korea: why they moved
1 article(s) on Korean Phase 3 trial stocks, checked against filings and numbers.